PBH · Prestige Consumer Healthcare Inc.
Market Cap
$2.48B
Shares
47.37M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$1.09B
-4.3%
FY2026
Net Income
$190.3M
-11.3%
FY2026
Gross Margin
54.71%
-1pp
FY2026
Operating Margin
28.42%
-1.2pp
FY2026
Diluted EPS
$3.91
-8.9%
FY2026
Operating Cash Flow
$257.63M
+2.4%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2027 (G) | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.29B – $1.32B | $1.1B | $1.09B | $1.14BG | $1.13B | $1.13B | $1.09B | $943.37M | $963.01M | $975.78M | $1.04B | $882.06M | $806.25M | $713.46M | $595.64M | $616.92M | $441.09M | $336.51M | $292.6M | |
| — | — | -$42.34M | -$47.63M | -$67.16M | -$69.16M | -$64.29M | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $513.45M | $493.13M | $503.3M | $500.91M | $502.43M | $466.17M | $395.89M | $410.79M | $420.2M | $464.67M | $381.77M | $339.04M | — | — | — | — | — | — | |
| — | $591.44M | $595.58M | $634.46M | $624.45M | $625.29M | $620.65M | $547.47M | $552.22M | $555.58M | $576.51M | $500.29M | $467.21M | $406.22M | $335.55M | $343.74M | $227.38M | $170.88M | $153.44M | |
| — | — | 54.71% | 55.76% | 55.49% | 55.45% | 57.11% | 58.03% | 57.34% | 56.94% | 55.37% | 56.72% | 57.95% | 56.94% | 56.33% | 55.72% | 51.55% | 50.78% | 52.44% | |
| — | $131.29M | $116.45M | $108.21M | $106.15M | $107.35M | $107.46M | $83.11M | $89.11M | $89.76M | $85.39M | $89.11M | $72.42M | $81.27M | $48.48M | $51.47M | $56.7M | $41.96M | $34.2M | |
| — | $18.35M | $17.92M | $18.26M | $19.78M | $22.27M | $21.5M | $19.58M | $19.63M | $21.77M | $23.35M | $19.75M | $18.43M | $13M | $10.26M | $11.68M | $9.99M | $9.21M | — | |
| — | $32.36M | $31.27M | $30.17M | $30.68M | $32.63M | $32.09M | $30.16M | $29M | $31.78M | $33.43M | $25.79M | $23.68M | $17.74M | $13.49M | $13.24M | $10.73M | $10.11M | $11.45M | |
| — | $301.26M | $286.17M | $297.69M | $282.02M | $647.71M | $290.73M | $250.07M | $261.07M | $488.07M | $361.03M | $294.64M | $206.9M | $198.66M | $146.94M | $151.85M | $124.56M | $94.73M | $75.12M | |
| — | $290.17M | $309.41M | $336.78M | $342.43M | -$22.42M | $329.92M | $297.4M | $291.16M | $67.5M | $215.47M | $205.64M | $260.32M | $207.56M | $188.62M | $191.88M | $102.82M | $76.15M | $78.33M | |
| — | — | 28.42% | 29.6% | 30.43% | -1.99% | 30.36% | 31.53% | 30.23% | 6.92% | 20.7% | 23.31% | 32.29% | 29.09% | 31.67% | 31.1% | 23.31% | 22.63% | 26.77% | |
| — | $322.53M | $340.68M | $366.95M | $373.1M | $10.21M | $362.01M | $327.57M | $320.15M | $99.28M | $248.9M | $231.44M | $283.99M | $225.3M | $202.1M | $205.12M | $113.56M | $86.25M | $89.78M | |
| — | — | — | $1.8M | $5.2M | $4.4M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $323K | — | — | — | — | — | — | $342K | $217K | $388K | $203K | $162K | $92K | $60K | $13K | $18K | $1000 | $1000 | |
| — | -$9.83M | -$9.57M | -$4.95M | $756K | -$2.34M | -$1.05M | $1.37M | -$1.63M | -$476K | $392K | -$30K | — | — | — | — | — | — | — | |
| — | — | $257.5M | $284.19M | $276.03M | -$93.92M | $262.46M | $204.11M | $191.15M | -$38.06M | $107.09M | $110.85M | $157.19M | $127.46M | $101.75M | $106.03M | $61.16M | $48.53M | $52.73M | |
| — | $62.25M | $67.2M | $69.58M | $66.69M | -$11.61M | $57.08M | $39.43M | $48.87M | -$2.26M | -$232.48M | $41.46M | $57.28M | $49.2M | $29.13M | $40.53M | $23.95M | $19.35M | $20.66M | |
| — | $172.01M | $190.3M | $214.61M | $209.34M | -$82.31M | $205.38M | $164.68M | $142.28M | -$35.8M | $339.57M | $69.4M | $99.91M | $78.26M | $72.62M | $65.51M | $37.21M | $29.22M | $32.12M | |
| — | — | 17.48% | 18.86% | 18.6% | -7.3% | 18.9% | 17.46% | 14.77% | -3.67% | 32.61% | 7.87% | 12.39% | 10.97% | 12.19% | 10.62% | 8.44% | 8.68% | 10.98% | |
| — | $174.59M | $199.59M | $211.44M | $206.41M | -$94.84M | $206.15M | $189.04M | $123.87M | -$42.23M | $346.61M | $66.57M | $99.79M | $54.11M | $73.46M | $65.41M | $37.2M | $29.22M | $33.45M | |
| USD/shares | — | $3.58 | $3.93 | $4.32 | $4.21 | -$1.65 | $4.09 | $3.28 | $2.81 | -$0.69 | $6.40 | $1.31 | $1.89 | $1.50 | $1.41 | $1.29 | $0.74 | $0.58 | $0.64 |
| USD/shares | — | $3.57 | $3.91 | $4.29 | $4.17 | -$1.65 | $4.04G | $3.25 | $2.78 | -$0.69 | $6.34 | $1.30 | $1.88 | $1.49 | $1.39 | $1.27 | $0.73 | $0.58 | $0.64 |
| shares | — | — | 48.46M | 49.7M | 49.76M | 49.89M | 50.26M | 50.21M | 50.72M | 52.07M | 53.1M | 52.98M | 52.75M | 52.17M | 51.64M | 50.63M | 50.27M | 50.08M | 50.01M |
| shares | — | — | 48.72M | 50.08M | 50.18M | 49.89M | 50.84M | 50.61M | 51.14M | 52.07M | 53.53M | 53.36M | 53.14M | 52.67M | 52.35M | 51.44M | 50.75M | 50.34M | 50.09M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2013–FY2026: $401.36M in buybacks, $0 in dividends.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
3.99×
Peer median 2.29×
EV/EBIT
15.18×
Peer median 21.72×
P/E (TTM)
14.64×
Peer median 17.16×
Peer medians compare against the 44 similar-size Drug Manufacturers - Specialty & Generic companies (of 100 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| North American OTC Healthcare | $913,576,000 | $960,010,000 | $958,260,000 | $973,774,000 | $967,881,000 | $849,319,000 | $859,368,000 | $862,446,000 |
| International OTC Healthcare | $175,129,000 | $177,752,000 | $167,097,000 | $153,951,000 | $118,931,000 | $94,046,000 | $103,642,000 | $93,520,000 |
| Household Cleaning | — | — | — | — | — | — | — | $19,811,000 |
By Geography (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| United States | $850,414,000 | $897,540,000 | $886,470,000 | $953,222,000 | $910,106,000 | $799,038,000 | $812,653,000 | $837,049,000 |
| Non Us | $238,291,000 | $240,222,000 | $238,887,000 | $174,503,000 | $176,706,000 | $144,327,000 | $150,357,000 | $138,728,000 |
By Product & Service (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Product | $1,084,744,000 | $1,136,581,000 | $1,125,046,000 | $1,127,618,000 | $1,086,770,000 | $943,324,000 | $962,936,000 | $975,692,000 |
| Gastrointestinal | $259,788,000 | $255,943,000 | $231,610,000 | $226,583,000 | $204,559,000 | $161,136,000 | $172,908,000 | $160,462,000 |
| Womens Health | $227,765,000 | $236,831,000 | $240,421,000 | $251,351,000 | $264,509,000 | $268,097,000 | $251,551,000 | $258,479,000 |
| Eye and Ear Care | $142,939,000 | $183,322,000 | $179,423,000 | $171,076,000 | $163,449,000 | $110,409,000 | $112,156,000 | $112,837,000 |
| Dermatologicals | $125,931,000 | $128,947,000 | $129,102,000 | $123,741,000 | $120,386,000 | $107,083,000 | $103,012,000 | $97,972,000 |
| Analgesics | $113,936,000 | $117,697,000 | $117,451,000 | $119,262,000 | $119,323,000 | $119,142,000 | $114,007,000 | $114,178,000 |
| Cough and Cold | $101,909,000 | $106,214,000 | $119,020,000 | $126,988,000 | $107,080,000 | $70,641,000 | $111,106,000 | $103,123,000 |
| Oral Care | $101,051,000 | $95,030,000 | $96,305,000 | $97,627,000 | $97,521,000 | $101,431,000 | $93,205,000 | $103,432,000 |
| Other Otc | $15,386,000 | $13,778,000 | $12,025,000 | $11,097,000 | $9,985,000 | $5,426,000 | $5,065,000 | $5,483,000 |
| Product And Service Other | $3,961,000 | $1,181,000 | $311,000 | $107,000 | $42,000 | $41,000 | $74,000 | $85,000 |
| Household Cleaning Department | — | — | — | — | — | — | $0 | $19,811,000 |
Key facts
CIK
1295947
CUSIP
74112D101
13F (30d)
204 filings
204 filers
Visit website
Investor relations